Immucell Value Stock - Dividend - Research Selection
Market price: 9,77 USD
Immucell Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||1.315.580|
|Free cash flow||-2.756.960|
|Liabilities & Shareholders equity||40.349.600|
|Diluted shares outstanding||7.213.330|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||70.474.232,00 USD|
|Raw Data Source||US GAAP in Millionen USD|
|Stock Split||1990-07-26,1.0000/100.0000; 1990-07-25,1.0000/100.0000; 1990-07-24,1.000000/100.000000|
Description of the company
ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. The Company´s product, First Defense, is manufactured from cows´ colostrum using the Company´s vaccine and whey protein purification technologies. The target disease, bovine enteritis (calf scours), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. First Defense is the only USDA-licensed, orally delivered scours preventive product on the market for calves with claims against E. coli K99 and coronavirus (two causes of scours). First Defense provides bovine antibodies that newborn calves need. Wipe Out Dairy Wipes consist of biodegradable towelettes that are pre-moistened with a Nisin to prepare the teat area of a cow in advance of milking.